A case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia

dc.contributor.authorPasin Hemachudha
dc.contributor.authorThanakit Pongpitakmetha
dc.contributor.authorWanakorn Rattanawong
dc.contributor.authorPoosanu Thanapornsungsuth
dc.contributor.authorYutthana Joyjinda
dc.contributor.authorSaowalak Bunprakob
dc.contributor.authorChanida Ruchisrisarod
dc.contributor.authorThiravat Hemachudha
dc.date.accessioned2026-05-08T19:18:05Z
dc.date.issued2022-1-1
dc.description.abstractCOVID-19 infection often results in an excessive inflammatory response with a spectrum of neurological manifestations. Here, we describe an 81-year-old female with severe COVID-19 pneumonia and subsequent alteration of consciousness after high-dose intravenous dexamethasone and remdesivir. A non-contrast head computed tomography (CT) demonstrated bilateral hypodensities involving bilateral cerebellar hemispheres, thalami, cerebral peduncles and medial parieto-occipital areas. There was no improvement and repeat CT showed progression with findings suggestive of acute necrotizing encephalopathy. Interleukin-6 levels were initially normal; however, subsequent levels were found to be markedly elevated. Acute necrotizing encephalopathy associated with COVID-19 may occur in the setting of severe pneumonia and may represent an immune-mediated process involving inflammatory cytokines such as interleukin-6.
dc.identifier.doi10.1177/2050313x221083653
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/16348
dc.publisherSAGE Open Medical Case Reports
dc.subjectInfectious Encephalopathies and Encephalitis
dc.subjectLong-Term Effects of COVID-19
dc.subjectCOVID-19 Clinical Research Studies
dc.titleA case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia
dc.typeArticle

Files

Collections